SKU: 24862678019

Evidence-Base Clin Chn Med (V17)

Sale price$144.12 Regular price$160.13
Save 10%

Pay in installments of $40.03 with ShopPay, AfterPay and Klarna

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Sep 5 - Sep 10

Promo Codes Available:

For Your Every Summer RSVP, with Code: SUMMER15

Description

Evidence-Base Clin Chn Med (V17)This seventeenth volume of the Evidence based Clinical Chinese Medicine series aims to provide a multi faceted "whole evidence" analysis of the management of Colorectal Cancer in integrative Chinese medicine. Beginning with overviews of how colorectal cancer is conceptualised and managed in both conventional medicine and contemporary Chinese medicine, the authors then provide detailed analyses of how colorectal cancer and related disorders were

This seventeenth volume of the Evidence-based Clinical Chinese Medicine series aims to provide a multi-faceted "whole evidence" analysis of the management of Colorectal Cancer in integrative Chinese medicine.

Beginning with overviews of how colorectal cancer is conceptualised and managed in both conventional medicine and contemporary Chinese medicine, the authors then provide detailed analyses of how colorectal cancer and related disorders were treated with herbal medicine and acupuncture in past eras.

In the subsequent chapters, the authors comprehensively review the current state of the clinical trial evidence for Chinese herbal medicines (Chapter 5), acupuncture (Chapter 7), other Chinese medicine therapies (Chapter 8) and combination Chinese medicine therapies (Chapter 9) in the management of colorectal cancer, as well as analyse and evaluate the results of these studies from an evidence-based medicine perspective. Chapter 6 provides a review and a summary of the experimental evidence for the bioactivity of commonly used Chinese herbs. The outcomes of these analyses are summarised and discussed in Chapter 10 which identifies implications for the clinical practice of Chinese medicine and for future research.

This book can inform clinicians and students in the fields of integrative medicine and Chinese medicine regarding contemporary practice and the current evidence-base for a range of Chinese medicine therapies used in the management of colorectal cancer, including herbal formulas and acupuncture treatments, in order to assist clinicians in making evidence-based decisions in patient care.

The following features mark the importance of this book in the field:

  • An innovative "whole evidence" approach: This book combines multiple types of evidence from multiple sources to provide a unique and comprehensive assessment of the available evidence for Chinese medicine in colorectal cancer.
  • Clinically informative and relevant: This book integrates the results of meta-analyses of clinical trial data with evidence from the classical Chinese medicine literature, and the recommendations in contemporary textbooks and clinical guidelines for the application of Chinese medicine.
  • Developed by a skilled team: The authors are internationally recognised, well-respected leaders in the field of Chinese medicine and evidence-based medicine with strong track records in research with multiple publications in the field of cancer.
Shipping Notes
  • Free Standard Shipping on $100+ Orders to the USA.
  • Except Preorder products are shipped in 48 hours.
  • Delivery to the USA:
  1. Standard Shipping : 3-10 business days
  • If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
SKU: 24862678019

Discover Niche Categories That Outsell

Top-Converting Item to Boost Your Average Order

4.1 ★★★★★
Based on 14 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
R
Verified Purchase
R. Willis
Omaha, US
★★★★★ 5
EPSON OEM ink....
Style: Ink
Good overpriced Epson ink. Tried aftermarket ink, worked FINE until Epson "update".....then got notice "invalid cartridge" and the printer would not operate. Bought OEM ink and it's happy again. I'm NOT.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 8, 2025
C
Verified Purchase
Cherrio
Los Angeles, US
★★★★★ 5
Cherrios
Style: Ink
Great Product
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 19, 2026
J
Verified Purchase
Jeryl
San Leandro, US
★★★★★ 4
Easy to put in, but ink doesn’t last and it is expensive
Style: Ink
The ink is great for my printer, but it doesn’t last long
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 14, 2026
N
Verified Purchase
Nadine Findley
Birmingham, US
★★★★★ 5
EPSON 822 DURABrite Ultra Ink High Capacity Black Cartridge is a great product
Style: Ink
EPSON 822 DURABrite Ultra Ink High Capacity Black Cartridge is a great product. The 822 XL size will last you a long time. The color is perfect. it fits my printer perfectly. A great product and at a great price. I received it the same day that I ordered it. I did not know that I was running out of the black. The printer sends me messages that I am running out but I ignore the message and keep on printing hundreds of papers. Do not listen to your printer just keep printing until the cartridge is completely empty!!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 14, 2025
G
Verified Purchase
Gary Shimmel
Natrona Heights, US
★★★★★ 5
Stick To The Originals
Style: Ink
Tried remanufactured and off brand cartridges and kept running into compatability issues with my Epson Work Force Pro WF-3820. These are more expensive-but they work. Have to take into consideration the fact that my printer is used for business and down time because my new cartridges aren't recognized by the printer costs $$$
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 1, 2026

recommand products